Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Two drugs widely used to treat certain autoimmune diseases substantially improved clinical status and reduced deaths.
However, Black people and uninsured folks with cancer were not as likely to access care via telemedicine.
Vaccines designed to produce a strong T cell response may help protect against current and future SARS-CoV-2 variants.
The good news is that only 4% of HIV-positive people experienced COVID breakthrough after vaccination.
NIH study finds high BMI and obesity raise infection risk, but asthma does not.
Women who reported chronic depression before the pandemic were 72% more likely to be hospitalized after COVID-19 diagnosis.
Health officials urge gay and bi men, in particular, to report unusual skin rashes and avoid close contact while symptomatic.
Using machine learning, researchers find patterns in electronic health record data to better identify those likely to have the condition.
People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.
With further testing, the antiviral proteins might be used as a nasal spray to prevent or treat COVID-19.
Nearly 200 cases of pediatric hepatitis have now been reported in more than a dozen countries and several states.
Remdesivir (Veklury) is now approved for kids ages 28 days to 12 years.
Antiviral drugs that target host cells may work against many existing and future variants of the virus that causes COVID-19.
The proportion without symptoms was higher than previously seen in many studies of both people with HIV and the general population.
The current leading suspect is an adenovirus, but much more remains to be learned.
A vaccine designed to enhance T-cell activity could help CAR-T therapy work better against solid tumors.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.